RFA-CA-25-007-Full-Announcement.html

This is a Notice of Funding Opportunity (NOFO) from the National Cancer Institute (NCI) seeking revision applications from currently funded NCI P50 specialized centers under grant number RFA-CA-25-007. The funding aims to expand existing research by incorporating new technical approaches or devices developed through the NCI Innovative Molecular Analysis Technologies (IMAT) program.

The opportunity is administered by the Department of Health and Human Services National Institutes of Health under CFDA 93.394 (Cancer Detection and Diagnosis Research). It is open to a wide range of applicants including nonprofits, higher education institutions, for-profit organizations, government entities, tribal organizations, and small businesses. The primary goal is to promote interdisciplinary collaboration in developing innovative cancer research tools and methods, specifically focusing on independent validation and accelerated adoption of emerging technologies by research communities. The funding will be provided as grants, though specific award amounts are not specified in this excerpt.